JPRN-jRCTs051180199招募中3 期
S1+ intravenous and intraperitoneal Paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis; Multicenter randomized phase III trial - S1+ intravenous and intraperitoneal Paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis; Multicenter randomized phase III trial
Satoi Sohei0 个研究点目标入组 180 人开始时间: 2019年3月26日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 80age old（—）
- 性别
- All
入选标准
- •Patients with peritoneal metastasis without other organ metastases
排除标准
- •Cytology positive in patients with resectable/borderiline resectable pancreatic ductal adenocarcinoma
研究者
相似试验
招募中
2 期
Intraperitoneal and intravenous paclitaxel plus S-1Gastric cancer with peritoneal metastasis or positive peritoneal cytology.JPRN-jRCTs061180008Fujiwara Yoshiyuki50
尚未招募
不适用
Treatment of abdominal mesothelioma with intra-abdominal chemotherapy - INTERACT MESONL-OMON26729one21
招募中
不适用
Intraperitoneal Paclitaxel for Patients with Primary Malignant Peritoneal Mesothelioma - a Phase I/II Dose Escalation and Safety StudyNL-OMON56619Erasmus MC, Universitair Medisch Centrum Rotterdam21
尚未招募
Unknown
Phase 3 study of Paclitaxel therapy and monolithic systemic chemotherapy in patients with gastric cancer and gastroesophageal border cancer with peritoneal metastasisNeoplasmsKCT0009110Koera University Guro Hospital117
已完成
2 期
Phase II study of intraperitoneal paclitaxel combined with S-1 plus cisplatin for advanced gastric cancer with peritoneal metastasisgastric cancer with peritoneal metastasisJPRN-UMIN000023000agoya University50